Search clinical trials for: lirentelimab

Total 8 results

Allakos Inc.

Active, not recruiting

A Study to Assess Subcutaneous Lirentelimab (AK002) in Atopic Dermatitis (ATLAS)

Atopic Dermatitis

United States, Germany
Allakos Inc.

Completed

A Study to Assess AK002 in Eosinophilic Gastritis and/or Eosinophilic Duodenitis (Formerly Referred to as Eosinophilic Gastroenteritis) (ENIGMA 2)

Eosinophilic Gastritis | Eosinophilic Duodenitis

United States
Allakos Inc.

Completed

An Extension Study of Lirentelimab in Eosinophilic Gastritis and/or Eosinophilic Duodenitis (Formerly Referred to as Eosinophilic Gastroenteritis)

Eosinophilic Gastritis | Eosinophilic Duodenitis

United States
Allakos Inc.

Completed

A Study of Lirentelimab (AK002) in Patients With Active Eosinophilic Duodenitis (EoDyssey)

Eosinophilic Gastroenteritis | Eosinophilic Duodenitis

United States
Allakos Inc.

Withdrawn

A Study to Assess Subcutaneous AK002 in Eosinophilic Gastritis and/or Eosinophilic Duodenitis (ENIGMA-SC)

Eosinophilic Gastritis | Eosinophilic Duodenitis

United States
Allakos Inc.

Completed

A Study of Lirentelimab (AK002) in Patients With Active Eosinophilic Esophagitis (KRYPTOS)

Eosinophilic Esophagitis

United States, Australia, Netherlands
Allakos Inc.

Completed

A Study to Evaluate Safety, Tolerability, and Bioavailability of Subcutaneous Lirentelimab (AK002) in Adult Healthy Volunteers

Study Conducted in Healthy Volunteers

United States
Allakos Inc.

Active, not recruiting

A Study to Assess Subcutaneous Lirentelimab (AK002) in Chronic Spontaneous Urticaria (MAVERICK)

Chronic Spontaneous Urticaria

United States, Germany, Poland

3

Subscribe